HomeInsightsPE

Auro Laboratories Ltd PE Ratio

Auro Laboratories Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

16.9 K

stocks traded

Last Updated time: 20 Sep 9.00 AM

Image

Auro Laboratories Ltd

NSE: AUROLABS

PE

15.5

Last updated: 20 Sep 9.00 AM

Key Highlights

  • The P/E Ratio of Auro Laboratories Ltd is 15.5 as of 20 Sep 9.00 AM.
  • The P/E Ratio of Auro Laboratories Ltd changed from 8.4 on March 2019 to 12.9 on March 2024 . This represents a CAGR of 7.41% over 6 years. .
  • The Latest Trading Price of Auro Laboratories Ltd is ₹ 192.9 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.7. In 2024.

Historical P/E Ratio of Auro Laboratories Ltd

No data available

Company Fundamentals for Auro Laboratories Ltd

No data available

Image

Auro Laboratories Ltd

NSE: AUROLABS

PRICE

192.9

-5.95 (-2.99%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Auro Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024192.9
18 Sep 2024198.85
17 Sep 2024203.2
16 Sep 2024200.1
13 Sep 2024192.95
12 Sep 2024193.5
11 Sep 2024190.5
10 Sep 2024188.9
09 Sep 2024184.3
06 Sep 2024188.55

SWOT Analysis Of Auro Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Auro Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Auro Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Auro Laboratories Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Auro Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Auro Laboratories Ltd

No data available

* All values are in %

About Auro Laboratories Ltd

  • Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL.
  • It is the first-line treatment for type 2 diabetes.
  • The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
  • The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
  • Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA.

Auro Laboratories Ltd News Hub

News

Auro Laboratories to announce Quarterly Result

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 August...

Read more

01 Aug 202412:55

News

Auro Laboratories to hold AGM

Auro Laboratories announced that the 35th Annual General Meeting (AGM) of the company will...

Read more

31 May 202416:59

News

Auro Laboratories to table results

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 25 May 2...

Read more

18 May 202417:29

News

Auro Laboratories to declare Quarterly Result

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 6 Februa...

Read more

01 Feb 202420:32

News

Auro Laboratories to table results

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 Novemb...

Read more

06 Nov 202315:29

News

Auro Laboratories to hold AGM

Auro Laboratories announced that the 34th Annual General Meeting (AGM) of the company will...

Read more

01 Sep 202312:55

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Auro Laboratories Ltd

What is the current PE Ratio of Auro Laboratories Ltd?

The Current PE Ratio of Auro Laboratories Ltd is 15.46 as on 20 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 20 Sep 2024.

What was the PE Ratio of Auro Laboratories Ltd last year?

The PE Ratio of Auro Laboratories Ltd was 13.94 last year, now the PE ratio is 15.46, showing a year-on-year growth of 10.9%.

What does the PE Ratio of Auro Laboratories Ltd indicate about its stock?

The PE Ratio of Auro Laboratories Ltd is 15.46. This ratio indicates that investors are willing to pay 15.46 times the earnings per share for each share of Auro Laboratories Ltd.

What is the PE Ratio Growth of Auro Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Auro Laboratories Ltd grew by 10.9% whereas, the EPS ratio grew by -67.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*